In the field of type 2 diabetes, blockade of IL-1β with IL-1 receptor antagonists reduced inflammation and improved and/or prevented diabetes in a rat model of type 2 diabetes [11], high-fat diet-fed mice [12] and in individuals with type 2 diabetes [13]. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.